COVID-19 Vaccine Effectiveness Against Medically Attended Symptomatic SARS-CoV-2 Infection Among Target Groups in Europe, October 2024-January 2025, VEBIS Primary Care Network. - Laniece Delaunay C; Verdasca N; Monge S; Domegan L; Sève N; Buda S; Meijer A; Lucaccioni H; López Torrijos M; McKenna A; Enouf V; Dürrwald R; et al. (Influenza and other respiratory viruses, 2025)